Abstract
Estrogen-induced cholestasis occurs in many women who are susceptible due to pregnancy or hormone replacement therapy for postmenopausal syndrome. 17α-Ethinylestradiol (EE), as a synthetic estrogen, has been widely used to study the underlying mechanisms of estrogen-induced cholestasis. Recent studies have also reported that liver kinase B1 (LKB1)-mediated activation of AMP-activated protein kinase (AMPK) plays a critical role in the regulation of canalicular network formation. However, the role of AMPK in EE-induced cholestasis remains to be determined. In this study, the effects of EE (1–100 µM) on AMPK activation and the expression of farnesoid X receptor (FXR) and hepatic bile acid transporters were examined in in vitro using 3D-cultured rat primary hepatocytes and in in vivo using rat cholestasis models. We also used specific chemical agonist and antagonist of AMPK, AMPK subunit-specific antibodies and lentiviral shRNAs for AMPKα1 and AMPKα2 to delineate the role of AMPK in EE-induced cholestasis and potential cellular mechanisms. We found that EE-induced phosphorylation of AMPKα1 via extracellular signal-regulated kinases-LKB1-mediated signaling pathways and subsequent nuclear translocation accounted for the down-regulation of FXR and bile acid transporters and disruption of bile acid homeostasis. Inhibition of AMPK activation using an AMPK antagonist Compound C (2 µM) or down-regulation of AMPKα1 using gene-specific shRNA attenuated EE-induced cholestasis both in in vitro and in in vivo. In conclusion, these results revealed that activation of cAMP-ERK-LKB1-AMPKα1 signaling pathway plays a critical role in EE-mediated dysregulation of the expression of FXR and bile acid transporters. AMPKα1 may represent an important therapeutic target for estrogen-induced cholestasis.
Similar content being viewed by others
Abbreviations
- ICP:
-
Intrahepatic cholestasis of pregnancy
- EE:
-
17α-Ethinylestradiol
- Bsep:
-
Bile salt export pump
- Mrp2:
-
Multidrug resistance-associated protein 2
- Ntcp:
-
Na+-dependent taurocholate cotransporter
- Oatp2:
-
Organic anion transporters 2
- FXR:
-
Farnesoid X receptor
- AMPK:
-
AMP-activated protein kinase
- LKB1:
-
Liver kinase B1
- ERK1/2:
-
Extracellular signal-regulated kinases
- ER:
-
Estrogen receptor
- TCA:
-
Taurocholate
- GPR30:
-
G protein-coupled receptor 30
- CC:
-
Compound C
- GAPDH:
-
Glyceraldehyde 3-phosphate dehydrogenase
References
Abu-Hayyeh S, Papacleovoulou G, Lovgren-Sandblom A et al (2013) Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype. Hepatology 57(2):716–726
Barth A, Klinger G, Rost M (2003) Influence of ethinyloestradiol propanolsulphonate on serum bile acids in healthy volunteers. Exp Toxicol Pathol 54(5):381–386
Chang HR, Nam S, Kook MC et al (2016) HNF4alpha is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer. Gut 65(1):19–32
Crocenzi FA, Sanchez Pozzi EJ, Pellegrino JM et al (2001) Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets. Hepatology 34(2):329–339
Eeckhoute J, Formstecher P, Laine B (2004) Hepatocyte nuclear factor 4alpha enhances the hepatocyte nuclear factor 1alpha-mediated activation of transcription. Nucleic Acids Res 32(8):2586–2593
Fu D, Wakabayashi Y, Lippincott-Schwartz J, Arias IM (2011) Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway. Proc Natl Acad Sci USA 108(4):1403–1408
Geier A, Dietrich CG, Gerloff T et al (2003) Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochim Biophys Acta 1609(1):87–94
Geier A, Martin IV, Dietrich CG et al (2008) Hepatocyte nuclear factor-4alpha is a central transactivator of the mouse Ntcp gene. Am J Physiol Gastrointest Liv Physiol 295(2):226–233
Gonzalez-Sanchez E, Firrincieli D, Housset C, Chignard N (2015) Nuclear receptors in acute and chronic cholestasis. Dig Dis 33(3):357–366
Gowans GJ, Hardie DG (2014) AMPK: a cellular energy sensor primarily regulated by AMP. Biochem Soc Trans 42(1):71–75
Hardie DG, Ashford ML (2014) AMPK: regulating energy balance at the cellular and whole body levels. Physiology 29(2):99–107
Henriquez-Hernandez LA, Flores-Morales A, Santana-Farre R et al (2007) Role of pituitary hormones on 17alpha-ethinylestradiol-induced cholestasis in rat. J Pharmacol Exp Ther 320(2):695–705
Homolya L, Fu D, Sengupta P et al (2014) LKB1/AMPK and PKA control ABCB11 trafficking and polarization in hepatocytes. PLoS ONE 9(3):e91921
Ju TC, Chen HM, Lin JT et al (2011) Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington’s disease. J Cell Biol 194(2):209–227
Jung D, Kullak-Ublick GA (2003) Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression. Hepatology 37(3):622–631
Jung D, Elferink MG, Stellaard F, Groothuis GM (2007) Analysis of bile acid-induced regulation of FXR target genes in human liver slices. Liv Int 27(1):137–144
Lee CG, Kim YW, Kim EH et al (2012) Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1. Gastroenterology 142(5):1206–1217
Li T, Chiang JY (2013) Nuclear receptors in bile acid metabolism. Drug Metab Rev 45(1):145–155
Lien F, Berthier A, Bouchaert E et al (2014) Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk. J Clin Investig 124(3):1037–1051
Liu X, LeCluyse EL, Brouwer KR et al (1999) Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration. Am J Physiol 277(1 Pt 1):12–21
Liu Y, Binz J, Numerick MJ et al (2003) Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Investig 112(11):1678–1687
Liu N, Meng Z, Lou G et al (2012) Hepatocarcinogenesis in FXR −/− mice mimics human HCC progression that operates through HNF1alpha regulation of FXR expression. Mol Endocrinol 26(5):775–785
Meng Q, Chen X, Wang C et al (2015) Protective effects of alisol B 23-Acetate via farnesoid X receptor-mediated regulation of transporters and enzymes in estrogen-induced cholestatic liver injury in mice. Pharm Res 32(11):3688–3698
Noh K, Kim YM, Kim YW, Kim SG (2011) Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein beta. Drug Metab Dispos 39(8):1451–1459
Novikova DS, Garabadzhiu AV, Melino G, Barlev NA, Tribulovich VG (2015) AMP-activated protein kinase: structure, function, and role in pathological processes. Biochem Biokhimiia 80(2):127–144
Pang Y, Dong J, Thomas P (2008) Estrogen signaling characteristics of Atlantic croaker G protein-coupled receptor 30 (GPR30) and evidence it is involved in maintenance of oocyte meiotic arrest. Endocrinology 149(7):3410–3426
Rahner C, Stieger B, Landmann L (1996) Structure-function correlation of tight junctional impairment after intrahepatic and extrahepatic cholestasis in rat liver. Gastroenterology 110(5):1564–1578
Ruiz ML, Rigalli JP, Arias A et al (2013) Induction of hepatic multidrug resistance-associated protein 3 by ethynylestradiol is independent of cholestasis and mediated by estrogen receptor. Drug Metab Dispos 41(2):275–280
Segovia N, Oberhauser E (1981) Sulfobromophthalein clearance tests before and after ethinyl estradiol administration, in women and men with familial history of intrahepatic cholestasis of pregnancy. Gastroenterology 81:226–231
Song X, Vasilenko A, Chen Y et al (2014) Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy. Hepatology 60(6):1993–2007
Stapleton D, Mitchelhill KI, Gao G et al (1996) Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271(2):611–614
Stepanov V, Stankov K, Mikov M (2013) The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders. J Recept Signal Transduct Res 33(4):213–223
Studer E, Zhou X, Zhao R et al (2012) Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology 55(1):267–276
Trauner M, Arrese M, Soroka CJ et al (1997) The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113(1):255–264
Van Mil SW, Milona A, Dixon PH et al (2007) Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 133(2):507–516
Williamson C, Geenes V (2014) Intrahepatic cholestasis of pregnancy. Obstet Gynecol 124(1):120–133
Wu X, Sun L, Zha W et al (2010) HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells. Gastroenterology 138(1):197–209
Xu H, Qin S, Carrasco GA et al (2009) Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus. Neuroscience 158(4):1599–1607
Yamamoto Y, Moore R, Hess HA et al (2006) Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity. J Biol Chem 281(24):16625–16631
Yang S, Wang J (2015) Estrogen activates AMP-activated protein kinase in human endothelial cells via ERbeta/Ca/Calmodulin-dependent protein kinase kinase beta pathway. Cell Biochem Biophys 72(3):701–707
Zhang L, Li J, Young LH, Caplan MJ (2006) AMP-activated protein kinase regulates the assembly of epithelial tight junctions. Proc Natl Acad Sci USA 103(46):17272–17277
Zucchetti AE, Barosso IR, Boaglio AC et al (2014) G-protein-coupled receptor 30/adenylyl cyclase/protein kinase a pathway is involved in estradiol 17ss-D-glucuronide-induced cholestasis. Hepatology 59(3):1016–1029
Acknowledgments
This work was supported by National Natural Science Foundation of China Grants (81320108029 to LZ; 81573514 to ZJ; 81070245, 81270489 to HZ); Specific Fund for Public Interest Research of Traditional Chinese Medicine, Ministry of Finance (201507004-002 to LZ), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Institutes of Heath Grant R01 DK-057543-11 (to PBH and HZ), VA Merit Awards (to HZ; I01BX001390); VCU Massey Cancer Pilot grant (A35362 to HZ).
Authors contribution
LX, PBH, ZJ, LZ and HZ conceived the original ideas, designed the study, analyzed the data and wrote the manuscript; LX, RL, LL, XC, LS, TW carried out the experiments and data analysis. ZJ and LZ contributed equally.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing financial interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Li, X., Liu, R., Luo, L. et al. Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats. Arch Toxicol 91, 481–494 (2017). https://doi.org/10.1007/s00204-016-1697-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-016-1697-8